Navigation Links
Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
Date:1/5/2012

2 earnings per share to be in the range of $3.10 to $3.20 on both a reported and non-GAAP basis.

The company anticipates 2012 revenue of between $21.8 and $22.8 billion. This includes an expected decline of over $3 billion in Zyprexa sales due to patent expirations in most markets outside of Japan. The reduction in revenue due to Zyprexa patent expirations is expected to be partially offset by growth in key franchises including Cymbalta, Cialis®, Humalog®, Humulin® and Forteo®, as well as continued growth of newer products such as Effient®, Axiron® and Tradjenta®. The company also anticipates continued strong, double-digit revenue growth from its Elanco Animal Health business. Both Japan and Emerging Markets are expected to post continued strong underlying volume growth; however, overall revenue growth in these markets in 2012 will be adversely affected by anticipated pricing actions in Japan and by the expected impact of patent expirations, including Zyprexa, in some emerging market countries.

The company anticipates that gross margin as a percent of revenue will be approximately 77 percent.

As a result of ongoing productivity efforts, the company expects to keep operating expenses essentially flat compared to 2011. Marketing, selling and administrative expenses are expected to be flat to declining and in the range of $7.4 billion to $7.8 billion. Research and development expense is expected to be flat to increasing and in the range of $5.0 billion to $5.3 billion.

Other income and deductions is expected to be in a range between net expense of $50 million and net income of $100 million.

The 2012 tax rate is expected to be approximately 21 percent, and assumes the extension of the R&D tax credit for the full year 2012.

Operating cash flows are expected to be more than sufficient to fund capital expenditures of approximately $800 million, as well as anticipated business development ac
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... has been appointed President and Chief Executive Officer, effective ... has stepped down from his executive and Board roles ... through the first quarter of 2016.  ...
(Date:9/22/2014)... 22, 2014 Research and Markets  has ... Diclofenac Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The diclofenac ...
(Date:9/22/2014)... SHENZHEN, China , Sept. 22, 2014 China Nepstar ... "Company"), a leading retail drugstore chain in China ... that it will hold its 2014 Annual General Meeting of Shareholders ... The AGM will be held at the meeting room of the ... District, Shenzhen , Guangdong Province ...
Breaking Medicine Technology:Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Global and Chinese Diclofenac Industry Report 2014 2China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2
... 3, 2010 The American College of Radiology (ACR) distributed ... ( MCR5 ) educational CD-ROM free of charge to physicians ... Mammography Case Review ( MCR5 ... improve their skills regarding the detection of cancers and other ...
... contract research organization will expand its operations in Chester County ... the Department of Community and Economic Development announced today. ... in Wayne, purchase new equipment and provide employee training. The ... three years and retain 80 existing positions.   ...
Cached Medicine Technology:ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities 2Research Facility Expansion Will Create, Retain More than 150 Jobs in Chester County 2
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- Teens and young adults ... behavioral counseling to help prevent risky sexual behaviors, according ... Force. Every year, about 20 million new sexually ... the United States. About half involve people between 15 ... Its new report, published Sept. 22 in ...
(Date:9/22/2014)... study pulls back the curtain on one of the ... and income between physicians who perform operations, procedures or ... perception, the research indicates, the physician payment system is ... doctors. , The new findings counter the widely held ... explains why doctors who perform procedures often earn nearly ...
(Date:9/22/2014)... September 22, 2014 Manhattan residents who ... side of the hip , which could be bursitis ... This treatment is now offered at New York Dynamic ... called trochanteric bursitis, occurs when the trochanteric bursa becomes ... in the hip, between the iliotibial band and the ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, 2014 ... 6 months and older be vaccinated for the upcoming flu ... vaccine recommendations to advise that the youngest kids should have ... also wants parents of children aged 2 to 8 to ... the flu shot if it,s readily available. "It,s important ...
(Date:9/22/2014)... MA Up to 40 percent of patients undergoing ... fail to remove all the cancerous tissue in the ... (BWH) have successfully tested a tool they developed that ... normal tissue, thereby decreasing the chances for repeat operations. ... the week of September 22, 2014 in the ...
Breaking Medicine News(10 mins):Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:The fine line between breast cancer and normal tissues 2
... States,Agency for International Development (USAID) is pleased to ... reduces the risk of,diarrhea. Sur,Eau is a water ... can be added to water immediately before,use and ... children and,people living with HIV and AIDS -- ...
... SAN DIEGO, April 25 SynergEyes, Inc., of ... designed for people,who need further vision correction after ... designed for patients who,have experienced some type of ... Every year, millions of people undergo LASIK ...
... Nonprofit Health Systems Research Institute as New Vice ... ... leader,and advocate on HIV/AIDS issues, has joined the nonprofit Altarum Institute,as Vice ... began the search for someone to lead our Community Health,Systems Group, I ...
... Comments Made by TV Game Show Host Spark Controversy, ... long-time host of,the television game show "The Price Is ... (CDOC), a non-profit group formed to,support responsible dog ownership. ... neuter law that went into effect this month in ...
... North Carolina-based Oaks,Development Group announced today ... Olympia Avenue, in Punta Gorda, Florida. The,29,927-square-foot ... near,Charlotte Regional Medical Center and currently includes ... converted to Oaks, unique,tenant-ownership model., Oaks, ...
... Tanzania, April 25 Today is a,great day for the ... a day to,celebrate. We celebrate because of the possibilities that ... by the United,Nations Secretary General His Excellency Ban Ki-Moon, presents ... is implemented to the,letter, millions of lives will be saved ...
Cached Medicine News:Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients 2Health News:Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute 2Health News:Bob Barker's 'Right' to Free Speech Comes with a 'Price' 2Health News:Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida 2Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: